Most fAD patients are diagnosed before the age of 65 and have a background of mutations in numerous genes, including AβPP (amyloid-β precursor protein), PSEN1 (presenilin 1), and PSEN2 [5]. The gene discussed is APP; the disease is familial Alzheimer disease.